These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

401 related items for PubMed ID: 17644872

  • 1. Nephrogenic fibrosing dermopathy/nephrogenic systemic fibrosis.
    Hamilton-Persaud K, Ezell LD, Macklin JG.
    Nephrol Nurs J; 2007; 34(3):283-7; quiz 288. PubMed ID: 17644872
    [Abstract] [Full Text] [Related]

  • 2. Gadolinium--a specific trigger for the development of nephrogenic fibrosing dermopathy and nephrogenic systemic fibrosis?
    Grobner T.
    Nephrol Dial Transplant; 2006 Apr; 21(4):1104-8. PubMed ID: 16431890
    [No Abstract] [Full Text] [Related]

  • 3. [Nephrogenic fibrosing dermopathy].
    Engelen JW, Kooistra MP, Canninga-van Dijk MR, Toonstra J, Sigurdsson V.
    Ned Tijdschr Geneeskd; 2003 Dec 06; 147(49):2435-8. PubMed ID: 14694555
    [Abstract] [Full Text] [Related]

  • 4. Nephrogenic fibrosing dermopathy.
    Firoz BF, Hunzeker CM, Soldano AC, Franks AG.
    Dermatol Online J; 2008 May 15; 14(5):11. PubMed ID: 18627747
    [Abstract] [Full Text] [Related]

  • 5. Strong association between the use of gadolinium-based contrast agents with nephrogenic fibrosing dermopathy/nephrogenic systemic fibrosis.
    Jamboti J.
    Intern Med J; 2007 Jul 15; 37(7):508-9; author reply 509. PubMed ID: 17547734
    [No Abstract] [Full Text] [Related]

  • 6. Nephrogenic systemic fibrosis in advanced chronic kidney disease: a single hospital's experience in Taiwan.
    Chen W, Huang SL, Huang CS, Tsai MC, Lai HM, Lui CC, Eng HL, Chang HW, Lee CH, Chuang FR.
    Eur J Dermatol; 2009 Jul 15; 19(1):44-9. PubMed ID: 19059824
    [Abstract] [Full Text] [Related]

  • 7. Nephrogenic fibrosing dermopathy/nephrogenic systemic fibrosis in 2 patients with end-stage renal disease on hemodialysis.
    Kim RH, Ma L, Hayat SQ, Ahmed MM.
    J Clin Rheumatol; 2006 Jun 15; 12(3):134-6. PubMed ID: 16755242
    [Abstract] [Full Text] [Related]

  • 8. Nephrogenic systemic fibrosis, in patients with end-stage kidney disease on dialysis, in the greater Auckland region, from 2000-2006.
    Kendrick-Jones JC, Voss DM, De Zoysa JR.
    Nephrology (Carlton); 2011 Feb 15; 16(2):243-8. PubMed ID: 21272139
    [Abstract] [Full Text] [Related]

  • 9. Possible role of gadolinium in nephrogenic systemic fibrosis: report of two cases and review of the literature.
    Lim YL, Lee HY, Low SC, Chan LP, Goh NS, Pang SM.
    Clin Exp Dermatol; 2007 Jul 15; 32(4):353-8. PubMed ID: 17433041
    [Abstract] [Full Text] [Related]

  • 10. Nephrogenic systemic fibrosis/nephrogenic fibrosing dermopathy: a primer for radiologists.
    Prasad SR, Jagirdar J.
    J Comput Assist Tomogr; 2008 Jul 15; 32(1):1-3. PubMed ID: 18303280
    [Abstract] [Full Text] [Related]

  • 11. Nephrogenic systemic fibrosis: an overview.
    Cowper SE.
    J Am Coll Radiol; 2008 Jan 15; 5(1):23-8. PubMed ID: 18180005
    [Abstract] [Full Text] [Related]

  • 12. Nephrogenic fibrosing dermopathy associated with exposure to gadolinium-containing contrast agents--St. Louis, Missouri, 2002-2006.
    Centers for Disease Control and Prevention (CDC).
    MMWR Morb Mortal Wkly Rep; 2007 Feb 23; 56(7):137-41. PubMed ID: 17318112
    [Abstract] [Full Text] [Related]

  • 13. Nephrogenic fibrosing dermopathy/nephrogenic systemic fibrosis with diaphragmatic involvement in a patient with respiratory failure.
    Kucher C, Steere J, Elenitsas R, Siegel DL, Xu X.
    J Am Acad Dermatol; 2006 Feb 23; 54(2 Suppl):S31-4. PubMed ID: 16427988
    [Abstract] [Full Text] [Related]

  • 14. Nephrogenic systemic fibrosis: is gadolinium to be blamed?
    Jikki PN.
    J Assoc Physicians India; 2008 Nov 23; 56():915-6. PubMed ID: 19263697
    [No Abstract] [Full Text] [Related]

  • 15. Nephrogenic systemic fibrosis (nephrogenic fibrosing dermopathy).
    Galan A, Cowper SE, Bucala R.
    Curr Opin Rheumatol; 2006 Nov 23; 18(6):614-7. PubMed ID: 17053507
    [Abstract] [Full Text] [Related]

  • 16. Nephrogenic fibrosing dermopathy: report of two cases.
    Aires NB, Sotto MN, Nico MM.
    Acta Derm Venereol; 2007 Nov 23; 87(6):521-4. PubMed ID: 17989891
    [Abstract] [Full Text] [Related]

  • 17. Transmetallation and gadolinium: do low iron stores prevent the development of nephrogenic systemic fibrosis in high-risk end-stage renal disease patients?
    Panesar M, Boateng F, Patel SS, Masood SF, Mahajan P, Patel N, Murray B.
    Hemodial Int; 2010 Jul 23; 14(3):289-94. PubMed ID: 20662951
    [Abstract] [Full Text] [Related]

  • 18. Gadolinium deposition in nephrogenic fibrosing dermopathy.
    Boyd AS, Zic JA, Abraham JL.
    J Am Acad Dermatol; 2007 Jan 23; 56(1):27-30. PubMed ID: 17109993
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Extracorporeal photopheresis improves nephrogenic fibrosing dermopathy/nephrogenic systemic fibrosis: three case reports and review of literature.
    Mathur K, Morris S, Deighan C, Green R, Douglas KW.
    J Clin Apher; 2008 Jan 23; 23(4):144-50. PubMed ID: 18633995
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.